全球阿片類藥物市場規模研究和預測：按產品類型（美沙酮,可待因,芬太尼,羥考酮,嗎啡,氫可酮）,應用（疼痛管理,咳嗽/腹瀉治療）區域分析2022-2029

2021 年全球阿片類藥物市場價值約為 226.6 億美元，預計在 2022-2029 年預測期內將以超過 1.2% 的健康增長率增長。

阿片類藥物是通過作用於阿片受體發揮嗎啡作用的醫療藥物，用於包括麻醉在內的鎮痛□□。 市場增長是由這些因素推動的，再加上人口中慢性疼痛發病率的增加、這些藥物的消費量增加以對抗疼痛以及老年人口的增加。

產品批准數量的增加和用於治療慢性疼痛患者的新型阿片類藥物的推出正在促進市場增長。 例如，2020 年 8 月，FDA（食品藥品監督管理局）批准了 Trevena 開發的奧林匹克（Olycerin）注射液。 這種新型注射劑專為治療成人急性疼痛而開發，每 10 毫升的成本約為 194 美元。 因此，阿片類藥物相關療法的監管批准和推出正在對全球市場增長產生積極影響。 此外，研發活動投資的增加和醫療費用的上漲在預測期內提供了各種有利可圖的機會。 然而，對阿片類藥物處方實施嚴格的政府法規和增加阿片類藥物成癮（阿片類藥物危機）限制了整個 2022-2029 年預測期內的市場增長。

全球阿片類藥物市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於基於阿片類藥物的批准增加以及未滿足的醫療需求，北美在收入方面佔據了市場主導地位。 另一方面，由於政府舉措的增加以及對提供用於疼痛管理的高質量阿片類藥物的更加關注等因素，預計亞太地區在預測期內將以最高的複合年增長率增長。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在包括被調查國家工業的定性和定量方面。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 阿片類藥物市場：地區，2019-2029
  • 阿片類藥物市場：按產品類型分類，2019-2029 年
  • 阿片類藥物市場，按應用，2019-2029
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章。全球阿片類藥物市場的定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第 3 章全球阿片類藥物市場動態

• 阿片類藥物市場影響分析 (2019-2029)
  • 市場驅動力
    • 新阿片類藥物的產品批准數量和引進數量增加
    • 人群中慢性疼痛的發病率增加
  • 市場挑戰
    • 對阿片類藥物處方執行嚴格的政府法規
    • 阿片類藥物成癮率上升（阿片類藥物危機）
  • 市場機會
    • 增加研發投資
    • 醫療費用增加

第 4 章全球阿片類藥物市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 頂級投資機會
• 關鍵成功策略
• 行業專家的展望
• 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球阿片類藥物市場：按產品類型分類

• 市場概況
• 阿片類藥物的全球市場：按產品類型分類的性能潛力分析
• 2019-2029 年全球阿片類藥物市場、按產品類型估算和預測
• 全球阿片類藥物市場，按細分市場分析
  • 美沙酮
  • 可待因
  • 芬太尼
  • 羥考酮
  • 嗎啡
  • 氫可酮
  • 其他

第 7 章。全球阿片類藥物市場：按應用

• 市場概況
• 阿片類藥物的全球市場：按應用分類的性能潛力分析
• 世界阿片類藥物市場、按應用估算和預測（2019 年至 2029 年）
• 全球阿片類藥物市場細分分析
  • 疼痛管理
  • 止咳藥
  • 腹瀉治療

第 8 章阿片類藥物的全球市場：區域分析

• 阿片類藥物全球市場、區域市場概況
• 北美
  • 美國
    • 按產品類型估算和預測，2019 年至 2029 年
    • 按應用分類的估計和預測，2019-2029 年
  • 加拿大
• 歐洲阿片類藥物市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太地區阿片類藥物市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲阿片類藥物市場概況
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 世界其他地方

第 9 章衝突信息

• 頂級市場策略
• 公司簡介
  • 梯瓦製藥工業有限公司
    • 主要信息
    • 概覽
    • 財務信息（取決於數據可用性）
    • 產品概述
    • 近期趨勢
  • Purdue Pharma LP
  • AstraZeneca Plc
  • C.H. Boehringer Sohn Ag and Co. Kg
  • Johnson & Johnson, Inc.
  • Sanofi S.A.
  • Mallinckrodt Pharmaceuticals
  • Endo Pharmaceuticals Inc.
  • Pfizer, Inc.
  • Sun Pharmaceuticals Industries Limited

第 10 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Opioids Market is valued at approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 1.2% over the forecast period 2022-2029. Opioids are medical agents that act on opioid receptors to cause morphine effects, which are used for pain relief, including anaesthesia. The market growth is driven by the factors such as increasing incidences of chronic pain among the population, a rise in consumption of these drugs to combat pain, coupled with the escalating geriatric population.

The rising number of product approval and the introduction of novel opioid medicines to cure patients suffering from chronic pain are acting as catalyzing factors for the growth of the market. For instance, in August 2020, Olinvyk (oliceridine) injection developed by Trevena, Inc., received Food and Drug Administration (FDA) approval. This new injection is developed to treat adults with acute pain that costs around USD 194 for a supply of 10 ml. Thereby, the rising launch of opioids-associated therapeutics with regulatory approvals is exhibiting a positive influence on market growth across the world. Moreover, growing investments in R&D activities, as well as the increasing healthcare expenditure are presenting various lucrative opportunities over the forecasting years. However, the execution of stringent government regulations for opioid prescription and the rise in opioid addiction (opioid crisis) is restricting the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Opioids Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising increasing approval of opioid-based medicines, along with the unmet medical needs. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing number of initiatives undertaken by the government, as well as rising focus on providing high-quality opioids intended for pain management in the market space.

Major market players included in this report are:

Teva Pharmaceutical Industries Limited

Purdue Pharma LP

AstraZeneca Plc

C.H. Boehringer Sohn Ag and Co. Kg

Johnson & Johnson, Inc.

Sanofi S.A.

Mallinckrodt Pharmaceuticals

Endo Pharmaceuticals Inc.

Pfizer, Inc.

Sun Pharmaceuticals Industries Limited

Recent Developments in the Market:

• In August 2022, Adalvo announced the acquisition of Onsolis a branded opioid product from a reputed U.S.-based specialty pharmacy company. The product is specially designed to indicate the management of chronic pain in cancer. The objective of this acquisition is to expand the company's opioid product portfolio and present a high-growth opportunity for the company.

Global Opioids Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Methadone

Codeine

Fentanyl

Oxycodone

Morphine

Hydrocodone

Others

By Application:

Pain Management

Cough Treatment

Diarrhea Treatment

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Opioids Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Opioids Market, by Product Type, 2019-2029 (USD Billion)
  • 1.2.3. Opioids Market, by Application, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Opioids Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Opioids Market Dynamics

• 3.1. Opioids Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising number of product approval and the introduction of novel opioid medicines
    • 3.1.1.2. Increasing incidences of chronic pains among the population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Execution of stringent government regulations for opioid prescription
    • 3.1.2.2. Rise in opioid addiction (opioid crisis)
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing investments in R&D activities
    • 3.1.3.2. Increasing healthcare expenditure

Chapter 4. Global Opioids Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Opioids Market, by Product Type

• 6.1. Market Snapshot
• 6.2. Global Opioids Market by Product Type, Performance - Potential Analysis
• 6.3. Global Opioids Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
• 6.4. Opioids Market, Sub Segment Analysis
  • 6.4.1. Methadone
  • 6.4.2. Codeine
  • 6.4.3. Fentanyl
  • 6.4.4. Oxycodone
  • 6.4.5. Morphine
  • 6.4.6. Hydrocodone
  • 6.4.7. Others

Chapter 7. Global Opioids Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Opioids Market by Application, Performance - Potential Analysis
• 7.3. Global Opioids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Opioids Market, Sub Segment Analysis
  • 7.4.1. Pain Management
  • 7.4.2. Cough Treatment
  • 7.4.3. Diarrhea Treatment

Chapter 8. Global Opioids Market, Regional Analysis

• 8.1. Opioids Market, Regional Market Snapshot
• 8.2. North America Opioids Market
  • 8.2.1. U.S. Opioids Market
    • 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Opioids Market
• 8.3. Europe Opioids Market Snapshot
  • 8.3.1. U.K. Opioids Market
  • 8.3.2. Germany Opioids Market
  • 8.3.3. France Opioids Market
  • 8.3.4. Spain Opioids Market
  • 8.3.5. Italy Opioids Market
  • 8.3.6. Rest of Europe Opioids Market
• 8.4. Asia-Pacific Opioids Market Snapshot
  • 8.4.1. China Opioids Market
  • 8.4.2. India Opioids Market
  • 8.4.3. Japan Opioids Market
  • 8.4.4. Australia Opioids Market
  • 8.4.5. South Korea Opioids Market
  • 8.4.6. Rest of Asia Pacific Opioids Market
• 8.5. Latin America Opioids Market Snapshot
  • 8.5.1. Brazil Opioids Market
  • 8.5.2. Mexico Opioids Market
  • 8.5.3. Rest of Latin America Opioids Market
• 8.6. Rest of The World Opioids Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Teva Pharmaceutical Industries Limited
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Purdue Pharma LP
  • 9.2.3. AstraZeneca Plc
  • 9.2.4. C.H. Boehringer Sohn Ag and Co. Kg
  • 9.2.5. Johnson & Johnson, Inc.
  • 9.2.6. Sanofi S.A.
  • 9.2.7. Mallinckrodt Pharmaceuticals
  • 9.2.8. Endo Pharmaceuticals Inc.
  • 9.2.9. Pfizer, Inc.
  • 9.2.10. Sun Pharmaceuticals Industries Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Opioids Market, report scope
• TABLE 2. Global Opioids Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Opioids Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
• TABLE 4. Global Opioids Market estimates & forecasts by Application 2019-2029 (USD Billion)
• TABLE 5. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Opioids Market
• TABLE 70. List of primary sources, used in the study of global Opioids Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Opioids Market, research methodology
• FIG 2. Global Opioids Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Opioids Market, key trends 2021
• FIG 5. Global Opioids Market, growth prospects 2022-2029
• FIG 6. Global Opioids Market, porters 5 force model
• FIG 7. Global Opioids Market, pest analysis
• FIG 8. Global Opioids Market, value chain analysis
• FIG 9. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Opioids Market, regional snapshot 2019 & 2029
• FIG 15. North America Opioids Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Opioids Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Opioids Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Opioids Market 2019 & 2029 (USD Billion)
• FIG 19. Global Opioids Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable